Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor

Neuroreport. 2001 Jul 20;12(10):2215-9. doi: 10.1097/00001756-200107200-00034.

Abstract

The neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) has been proposed to have a role in nociception. Here we have used the formalin test, thermal laser stimulation and mechanical von Frey stimulation to investigate possible alteration of PAC1-/- mice nociceptive behaviour. Our finding, that PAC1-/- mice have a substantial, 75% decrease in nociceptive response during the late phase, provides clear evidence that the specific PACAP-receptor PAC1 is involved in the mediation of nociceptive responses during chronic conditions such as inflammation. PAC1-/- mice had small or no changes in the response to mechanical and thermal laser stimulation. This suggests a limited, if any, involvement of PAC1 in nociception after short-lasting stimuli. Injury-induced changes in DRG neuropeptide expression were more pronounced in PAC1-/- mice, implying neuroregulatory functions of PAC1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Ganglia, Spinal / metabolism
  • Ganglia, Spinal / physiopathology
  • Male
  • Mice
  • Mice, Knockout
  • Neuropeptides / metabolism*
  • Neuroprotective Agents / metabolism*
  • Pain Measurement* / methods
  • Pain Threshold / physiology*
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • Receptors, Pituitary Hormone / deficiency*
  • Receptors, Pituitary Hormone / genetics*
  • Sciatic Nerve / physiopathology
  • Spinal Cord / metabolism
  • Spinal Cord / physiopathology

Substances

  • Adcyap1 protein, mouse
  • Adcyap1r1 protein, mouse
  • Neuropeptides
  • Neuroprotective Agents
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • Receptors, Pituitary Hormone